ViCCY: Improving Self-Care of Behavioral Variant Frontotemporal Dementia Caregivers

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT04686266
Collaborator
(none)
30
1
2
10.6
2.8

Study Details

Study Description

Brief Summary

The research study is being conducted to evaluate the efficacy of a virtual support intervention to reduce stress and poor self-care for caregivers of persons with behavioral variant Frontotemporal Degeneration (bvFTD) compared to receiving health information alone.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health Information + Health Coaching
N/A

Detailed Description

Informal caregivers of persons with Frontotemporal degeneration (FTD) are an understudied population with unique needs. FTD is a common cause of young-onset dementia with no known cure. Behavioral variant FTD (bvFTD) is the most common of the FTD syndromes and involves a progressive disorder of emotional regulation and personality, and significant impairment in executive function. bvFTD caregivers face unique challenges which are particularly stressful, including young age at which the disorder appears, behavioral symptoms like apathy and disinhibition that are severe and appear early in bvFTD, and the lack of appropriate supportive services. Indeed, numerous studies have demonstrated that stress, depression and burden are higher in FTD caregivers than in any of the other ADRDs, yet caregiver interventions tested in specifically in the FTD population have been limited to a few small studies that focus on education around patient behavior management, not caregiver self-care.

The research study is being conducted to evaluate the efficacy of a virtual support intervention to reduce stress and poor self-care for caregivers of persons with behavioral variant Frontotemporal Degeneration (bvFTD) compared to receiving health information alone.

30 caregivers will be randomized 1:1 to a health information: health information + health coaching group. Catered information will be delivered via tablets over 6 months with testing dispersed at baseline, 1 month, 3 months, and 6 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Investigators and all staff involved in collecting assessment data will be blinded to group assignment until after the data are locked. The Health Coaches providing the intervention and the caregiver participants will not be blinded.
Primary Purpose:
Treatment
Official Title:
Efficacy of a Virtual Intervention for Informal Caregivers of Adults With Frontotemporal Dementia
Actual Study Start Date :
Dec 16, 2020
Actual Primary Completion Date :
Nov 3, 2021
Actual Study Completion Date :
Nov 3, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: ViCCY: Health Information + Health Coaching

This group will receive 10 front-loaded sessions of virtual health coaching by trained Health Coaches over 6 months with content based on the theoretical framework our prior research. Sessions are provided using tablets. Initially, sessions are weekly to build the relationship, but the frequency of sessions decreases over time

Behavioral: Health Information + Health Coaching
Virtual Health Coaching for You: The focus of these sessions is helping caregivers take care of themselves. These are virtual health coaching sessions by trained Health Coaches over 6 months with content based on the theoretical framework from our prior research
Other Names:
  • ViCCY
  • No Intervention: Health Information

    Caregivers in the Health Information group are asked to spend at least 30 minutes weekly using the computer tablet provided to you by the study team to access recommended websites

    Outcome Measures

    Primary Outcome Measures

    1. Change from Baseline in the Self-Care Inventory [3 months and 6 months]

      30 items scored 0-100. A higher score indicates better self-care. This theoretically-derived instrument has construct validity. The self-care confidence scale is embedded within this instrument.

    2. Change from Baseline in Frontotemporal Dementia Rating Scale [3 months and 6 months]

      Commonly used scale to quantify behavioral and psychological symptoms of dementia

    Secondary Outcome Measures

    1. Change from Baseline in Perceived Stress Scale [3 months and 6 months]

      The Perceived Stress Scale, a 14-item instrument that provides a global rating of an individual's belief in the severity and frequency of stressful experiences during the last month. The Perceived Stress Scale includes 14 items designed to assess symptoms of stress and global measures of the degree of stress experienced in the past month. Each item is scored from 0 (never) to 4 (very often), with total sum scores ranging from 0 to 56; higher scores indicate higher perceived stress. Cronbachs alpha of the scale ranges from 0.84 to 0.86, and was 0.91 for older African American and European American females.

    2. Change from Baseline in Center for Epidemiologic Studies Depression Scale (CES-D) [3 months and 6 months]

      CES-D is a valid and reliable scale for detecting caregiver depression in dementia.

    3. Change from Baseline in Ways of Coping Questionnaire, short form [3 months and 6 months]

      This 42-item questionnaire measures the use of five different coping styles: avoidance, problem-focused, seeking social support, self-blame, and wishful thinking. The original scale has been used widely since developed by Lazarus in 1985. The short version (30 items) uses a 4-point Likert-scale response format (0 = not used to 3 = used a great deal). Scores range from 0-90 with higher scores indicating greater coping. It is reliable (alpha 0.95) and has construct validity. This instrument has been used numerous times in studies with older adult caregivers.

    4. Change from Baseline in Zarit Burden Interview (ZBI) [3 months and 6 months]

      The ZBI has been used in numerous informal dementia caregiver studies to capture burden associated with providing care to a loved one. Total scores are summed and a range is provided for little to no burden (0-21) to severe burden (61-88).

    5. Change from Baseline in Medical Outcomes Study Short Form (SF-36) [3 months and 6 months]

      subjective review of caregiver health information

    6. Change from Baseline in Neuropsychiatric Inventory [3 months and 6 months]

      Commonly used scale to quantify behavioral and psychological symptoms of dementia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Informal caregiver providing care at least 8 hours/week

    • Reporting poor self-care on screening (Health Self-Care Neglect Scale, score ≥ 2)

    • Able to complete the protocol, e.g., adequate vision and hearing, English speaking

    • Caregiver of a patient diagnosed bvFTD

    Exclusion Criteria:
    • Participation in another support randomized, controlled trial

    • Untreated major psychiatric illness (Use of anti-anxiety/anti-depressant medicines is acceptable and will be adjusted in analysis if group imbalance is identified.)

    • Caregiver with Cognitive Impairment based on Telephone Interview for Cognitive Status (TICS) score <25

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pennsylvania, School of Nursing Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • University of Pennsylvania

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Pennsylvania
    ClinicalTrials.gov Identifier:
    NCT04686266
    Other Study ID Numbers:
    • 843660
    First Posted:
    Dec 28, 2020
    Last Update Posted:
    Jan 11, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 11, 2022